Skip to main content

Table 2 MIC assays of H1, H2, H3, H6, H8, NZ2114, and vancomycin against G+ and G− pathogens

From: Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus

Strains

MIC (μM)

H1

H2

H3

H6

H8

NZ

Van

Gram-positive bacteria

 S. aureus ATCC25923

0.014

0.028

0.014

0.028

0.028

0.028a

0.172

 S. aureus ATCC43300

0.057

0.114

0.057

0.114

0.454

0.909a

0.714

 S. aureus ATCC6538

0.057

0.057

0.114

0.114

0.227

0.114a

1.428

 S. suis CVCC3309

0.014

0.028

0.014

0.028

0.028

0.028

0.172b

 S. suis CVCC3928

0.007

0.014

0.028

0.014

0.057

0.028

0.172b

 S. suis CVCC606

0.007

0.028

0.028

0.014

0.028

0.028

0.172b

 S. pneumoniae CVCC1.8722

0.227

0.227

0.454

0.454

1.818

0.454

NT

 S. pneumoniae CVCC2350

0.227

0.227

0.227

0.454

1.818

0.909

NT

Gram-negative bacteria

 S. enteritidis CMCC50336

>7.273

>7.273

>7.273

>7.273

>7.273

>7.273

NT

 S. typhimurium ATCC14028

>7.273

>7.273

>7.273

>7.273

>7.273

>7.273

NT

 S. choleraesuis CVCC503

>7.273

>7.273

>7.273

>7.273

>7.273

>7.273

NT

 S. pullorum CVCC1789

>7.273

>7.273

>7.273

>7.273

>7.273

>7.273

NT

 E. coli CVCC195

>7.273

>7.273

>7.273

>7.273

>7.273

>7.273

NT

 E. coli CICC21530

>7.273

>7.273

>7.273

>7.273

>7.273

>7.273

NT

  1. NZ NZ2114, Van vancomycin, NT no test
  2. aThe data are from previous results (Zhang et al. 2014)
  3. bThe data are from previous results (Jiao et al. 2015)